Stimulation of the Growth of Metastatic Clones of Mouse Colon Adenocarcinoma 26 in vitro by Platelet‐derived Growth Factor

Por Tsuruo, Takashi, Watanabe, Masahiko, Oh‐hara, Tomoko
Publicado no Jpn J Cancer Res (1989)

Platelets promote osteosarcoma cell growth through activation of the platelet-derived growth factor receptor-Akt signaling axis

Por Takagi, Satoshi, Takemoto, Ai, Takami, Miho, Oh-hara, Tomoko, Fujita, Naoya
Publicado no Cancer Sci (2014)

In vitro Antitumor Activity of TAS‐103, a Novel Quinoline Derivative That Targets Topoisomerases I and II

Por Aoyagi, Yoshimi, Kobunai, Takashi, Utsugi, Teruhiro, Oh‐hara, Tomoko, Yamada, Yuji
Publicado no Jpn J Cancer Res (1999)

Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis

Por Takagi, Satoshi, Oh-hara, Tomoko, Sato, Shigeo, Gong, Bo, Takami, Miho, Fujita, Naoya
Publicado no Int J Cancer (2014)

Modulation of Multidrug Resistance by SDZ PSC 833 in Leukemic and Solid‐tumor‐bearing Mouse Models

Por Watanabe, Toru, Naito, Mikihiko, Oh‐hara, Tomoko, Itoh, Yohjiro, Cohen, Dalia, Tsuruo, Takashi
Publicado no Jpn J Cancer Res (1996)

Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin‐resistant Subline of Human Colon Carcinoma

Por Yanase, Kae, Sugimoto, Yoshikazu, Tsukahara, Satomi, Oh‐hara, Tomoko, Andoh, Toshiwo, Tsuruo, Takashi
Publicado no Jpn J Cancer Res (2000)

Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2

Por Takagi, Satoshi, Sato, Shigeo, Oh-hara, Tomoko, Takami, Miho, Koike, Sumie, Mishima, Yuji, Hatake, Kiyohiko, Fujita, Naoya
Publicado em 2013

Cytotoxic activity of Tivantinib (ARQ 197) is not due solely to MET inhibition

Por Katayama, Ryohei, Aoyama, Aki, Yamori, Takao, Qi, Jie, Oh-hara, Tomoko, Song, Youngchul, Engelman, Jeffrey A., Fujita, Naoya
Publicado em 2013

Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer

Por Takahashi, Ken, Seto, Yosuke, Okada, Koutaroh, Uematsu, Shinya, Uchibori, Ken, Tsukahara, Mika, Oh‐hara, Tomoko, Fujita, Naoya, Yanagitani, Noriko, Nishio, Makoto, Okubo, Kenichi, Katayama, Ryohei
Publicado no Thorac Cancer (2020)

Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance

Por Okada, Koutaroh, Araki, Mitsugu, Sakashita, Takuya, Ma, Biao, Kanada, Ryo, Yanagitani, Noriko, Horiike, Atsushi, Koike, Sumie, Oh-hara, Tomoko, Watanabe, Kana, Tamai, Keiichi, Maemondo, Makoto, Nishio, Makoto, Ishikawa, Takeshi, Okuno, Yasushi, Fujita, Naoya, Katayama, Ryohei
Publicado no EBioMedicine (2019)

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models

Por Katayama, Ryohei, Gong, Bo, Togashi, Noriko, Miyamoto, Masaya, Kiga, Masaki, Iwasaki, Shiho, Kamai, Yasuki, Tominaga, Yuichi, Takeda, Yasuyuki, Kagoshima, Yoshiko, Shimizu, Yuki, Seto, Yosuke, Oh-hara, Tomoko, Koike, Sumie, Nakao, Naoki, Hanzawa, Hiroyuki, Watanabe, Kengo, Yoda, Satoshi, Yanagitani, Noriko, Hata, Aaron N., Shaw, Alice T., Nishio, Makoto, Fujita, Naoya, Isoyama, Takeshi
Publicado no Nat Commun (2019)